The U.S. Hemp Roundtable (“the Roundtable”) appreciates the opportunity to provide comments to FDA in response to its request for scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds. The Roundtable is the hemp industry’s leading business advocacy organization, committed to fostering regulatory discussions about hemp products and building an accountable industry. With members from more than seventy firms from across the country, the Roundtable’s Board of Directors and members constitute many of the hemp industry’s largest businesses. We are also closely aligned with the Hemp Industries Association (“HIA”), the industry’s leading trade association and grassroots force. Together with HIA, the Roundtable has worked toward fostering increased accountability for the hemp-derived consumer product industry by providing high standards, best practices and self-regulation, giving confidence to consumers and law enforcement that hemp products are safe and legal.
Here is the full document submitted to the FDA2019.07.16-US-Hemp-Roundtable-FDA-Comments